Advertisement

Topics

NICE backs Jazz Pharma's AML chemotherapy Vyxeos

04:54 EST 9 Nov 2018 | SmartBrief

Jazz Pharmaceuticals' Vyxeos, or daunorubicin and cytarabine, has received approval from the UK's National Institute for Heal -More

Original Article: NICE backs Jazz Pharma's AML chemotherapy Vyxeos

NEXT ARTICLE

More From BioPortfolio on "NICE backs Jazz Pharma's AML chemotherapy Vyxeos"

Advertisement
Quick Search
Advertisement
Advertisement